Xingfu Li
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Journal: Therapeutic advances in musculoskeletal disease
Published: February 10, 2021
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Journal: Clinical and experimental rheumatology
Published: February 13, 2019
Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study.
Journal: International journal of rheumatic diseases
Published: October 23, 2018
Role of miR-9-5p in preventing peripheral neuropathy in patients with rheumatoid arthritis by targeting REST/miR-132 pathway.
Journal: In vitro cellular & developmental biology. Animal
Published: September 11, 2018
Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort.
Journal: Clinical and experimental rheumatology
Published: October 30, 2013
Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional study.
Journal: Arthritis care & research
Published: February 17, 2013
The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional study.
Journal: Rheumatology (Oxford, England)
Published: February 13, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026